Yield10 Bioscience: On May 18, Got Letter From Nasdaq That Co Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Portfolio Pulse from Benzinga Newsdesk
Yield10 Bioscience received a letter from Nasdaq on May 18 stating that the company is not in compliance with the minimum stockholders' equity requirement for continued listing.
May 19, 2023 | 8:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Yield10 Bioscience is not in compliance with Nasdaq's minimum stockholders' equity requirement, putting its continued listing at risk.
Yield10 Bioscience's non-compliance with Nasdaq's minimum stockholders' equity requirement puts its continued listing at risk. This could lead to a negative impact on the stock price as investors may lose confidence in the company's financial stability and future prospects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100